{"schema_version":"secwatch.filing_event.v1","accession":"0001703057-25-000034","form_type":"8-K","ticker":"ABCL","cik":"0001703057","company_name":"AbCellera Biologics Inc.","filed_at":"2025-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.199488+00:00","generated_at":"2026-05-16T12:45:19.254445+00:00","sec_items":["7.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AbCellera settles Bruker patent litigation; $36M upfront plus ongoing royalties","bullets":["Bruker to pay AbCellera $36 million upfront as part of global patent settlement.","Bruker will also pay future royalties on worldwide sales of its Beacon Optofluidic platform.","Settlement resolves all patent litigation between AbCellera and Bruker globally.","No other terms of the license agreement were disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001703057-25-000034","json":"https://secwatch.observer/filing/0001703057-25-000034.json","markdown":"https://secwatch.observer/filing/0001703057-25-000034.md","text":"https://secwatch.observer/filing/0001703057-25-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703057/000170305725000034/0001703057-25-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703057/000170305725000034/abcl-20251218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:45:19.254445+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}